New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease

Jesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, Lawrence Ang, John Bahadorani, Ryan R Reeves, Ehtisham Mahmud, Mitul Patel Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, CA, USA Abstract: Peripheral arterial disease (PAD) involving the lower e...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Naghi J, Yalvac EA, Pourdjabbar A, Ang L, Bahadorani J, Reeves RR, Mahmud E, Patel M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Drug-coated balloons Endovascular Percutaneous transluminal angioplasty Paclitaxel Peripheral arterial disease Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/592f1da128d24c60b478a19513926ecf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:592f1da128d24c60b478a19513926ecf
record_format	dspace
spelling	oai:doaj.org-article:592f1da128d24c60b478a19513926ecf2021-12-02T05:02:45ZNew developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease1179-1470https://doaj.org/article/592f1da128d24c60b478a19513926ecf2016-06-01T00:00:00Zhttps://www.dovepress.com/new-developments-in-the-clinical-use-of-drug-coated-balloon-catheters--peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Jesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, Lawrence Ang, John Bahadorani, Ryan R Reeves, Ehtisham Mahmud, Mitul Patel Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, CA, USA Abstract: Peripheral arterial disease (PAD) involving the lower extremity is a major source of morbidity and mortality. Clinical manifestations of PAD span the spectrum from lifestyle limiting claudication to ulceration and gangrene leading to amputation. Advancements including balloon angioplasty, self-expanding stents, drug-eluting stents, and atherectomy have resulted in high technical success rates for endovascular therapy in patients with PAD. However, these advances have been limited by somewhat high rates of clinical restenosis and clinically driven target lesion revascularization. The recent introduction of drug-coated balloon technology shows promise in limiting neointimal hyperplasia induced by vascular injury after endovascular therapies. This review summarizes the contemporary clinical data in the emerging area of drug-coated balloons. Keywords: drug-coated balloons, endovascular, percutaneous transluminal angioplasty, paclitaxel, peripheral arterial diseaseNaghi JYalvac EAPourdjabbar AAng LBahadorani JReeves RRMahmud EPatel MDove Medical PressarticleDrug-coated balloons Endovascular Percutaneous transluminal angioplasty Paclitaxel Peripheral arterial diseaseMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2016, Iss Issue 1, Pp 161-174 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Drug-coated balloons Endovascular Percutaneous transluminal angioplasty Paclitaxel Peripheral arterial disease Medical technology R855-855.5
spellingShingle	Drug-coated balloons Endovascular Percutaneous transluminal angioplasty Paclitaxel Peripheral arterial disease Medical technology R855-855.5 Naghi J Yalvac EA Pourdjabbar A Ang L Bahadorani J Reeves RR Mahmud E Patel M New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
description	Jesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, Lawrence Ang, John Bahadorani, Ryan R Reeves, Ehtisham Mahmud, Mitul Patel Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, CA, USA Abstract: Peripheral arterial disease (PAD) involving the lower extremity is a major source of morbidity and mortality. Clinical manifestations of PAD span the spectrum from lifestyle limiting claudication to ulceration and gangrene leading to amputation. Advancements including balloon angioplasty, self-expanding stents, drug-eluting stents, and atherectomy have resulted in high technical success rates for endovascular therapy in patients with PAD. However, these advances have been limited by somewhat high rates of clinical restenosis and clinically driven target lesion revascularization. The recent introduction of drug-coated balloon technology shows promise in limiting neointimal hyperplasia induced by vascular injury after endovascular therapies. This review summarizes the contemporary clinical data in the emerging area of drug-coated balloons. Keywords: drug-coated balloons, endovascular, percutaneous transluminal angioplasty, paclitaxel, peripheral arterial disease
format	article
author	Naghi J Yalvac EA Pourdjabbar A Ang L Bahadorani J Reeves RR Mahmud E Patel M
author_facet	Naghi J Yalvac EA Pourdjabbar A Ang L Bahadorani J Reeves RR Mahmud E Patel M
author_sort	Naghi J
title	New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
title_short	New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
title_full	New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
title_fullStr	New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
title_full_unstemmed	New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
title_sort	new developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/592f1da128d24c60b478a19513926ecf
work_keys_str_mv	AT naghij newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT yalvacea newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT pourdjabbara newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT angl newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT bahadoranij newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT reevesrr newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT mahmude newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease AT patelm newdevelopmentsintheclinicaluseofdrugcoatedballooncathetersinperipheralarterialdisease
_version_	1718400710485213184

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease

Ejemplares similares